Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus

Diabetic Medicine

Volumn 22, Issue 11, 2005, Pages 1530-1535

  Kwon, So Young ^a   Kim, S S ^a   Kwon, O S ^a   Kwon, K A ^a   Chung, M G ^a   Park, D K ^a   Kim, Y S ^a   Koo, Y S ^a   Kim, Y K ^a   Choi, D J ^a   Kim, J H ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Cirrhosis; Diabetes mellitus; Hepatitis C; Prognosis

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; BACTERIAL PERITONITIS; BLEEDING; CAUSE OF DEATH; DIABETES MELLITUS; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SEPSIS; SURVIVAL; VARICOSIS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; HYPERGLYCEMIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 27844449006     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01687.x     Document Type: Article

References (26)

1. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967; 2: 1051-1056.
2. Muting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics 1969; 24: 91-99.
3. Gentile S, Loguercio C, Marmo R, Carbone L, Del Vecchio Blanco C. Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract 1993; 22: 37-44.
4. Vidal J, Ferrer JP, Esmatjes E, Salmeron JM, Gonzalez-Clemente JM, Gomis R et al. Diabetes mellitus in patients with liver cirrhosis. Diabetes Res Clin Pract 1994; 25: 19-25.
5. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-333.
6. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-1139.
7. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-599.
8. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-1063.
9. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20: 119-125.
10. Kwon SY. Prevalence and clinical significance of diabetes mellitus in patients with liver cirrhosis. Korean J Hepatol 2003; 9: 205-211.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding varices. Br J Surg 1973; 60: 646-649.
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23: S4-S19.
15. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastreoenterol Hepatol 2002; 17: 677-681.
16. Maeno T, Okumura A, Ishikawa T, Kato K, Sakakibara F, Sato K et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003; 18: 1358-1363.
17. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001; 35: 279-283.
18. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384-1392.
19. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in non-cirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-359.
20. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
21. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669.
22. Kim YS, Pai CH, Chi HS, Kim DW, Min YI, Ahn YO. Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci 1992; 7: 333-336.
23. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol. Hepatology 2002; 36: 729-736.
24. Lee CJ, Shin WW, Ahn HS, Lee SW, Roh MH, Han SY et al. Genotype in patients with chronic liver disease associated with hepatitis C virus infection. Korean J Gastroenterol 2000; 35: 73-81.
25. Park YS, Kim TW. Liver cirrhosis and diabetes mellitus. Korean J Hepatol 2002; 8: 22-34.
26. Marchesini G, Ronchi M, Forlani G, Bugianesi B, Bianchi G, Fabbri A et al. Cardiovascular disease in cirrhosis. A point-prevalence study in relation to glucose tolerance. Am Gastroenterol 1999; 94: 655-662.